Commonly used in the treatment of bipolar disorder and other mood disorders, lithium could prove promising for inhibiting HIV ...

*Billed as $4.00 plus GST every four weeks. After 24 weeks, price increases to the regular rate of $19.95 plus GST every four weeks. Offer available to new and qualified returning subscribers only.

A former senior human resources executive at P&O Cruises is pursuing nearly £10 million in damages after claiming a fall on the company's flagship vessel left her unable to work again.

ETHealthworld.com brings latest neurological disorders news, views and updates from all top sources for the Indian Health industry.

A popular technique for studying brain disorders, known as lesion network mapping (LNM), appears to have a fundamental ...

Professor Jaewon Ko’s research team at DGIST, in collaboration with international researchers, identified that the loss of function of the MDGA2 gene induces severe developmental and epileptic encepha ...

Let's see what this stock has announced on Thursday. The post ASX 200 healthcare stock sinks 9% on FDA update appeared first ...

The crisis facing rare disease and disability families in Connecticut is caused by systemic underinvestment, administrative barriers, and policy choices.

A first-of-its-kind facility that blends Ayurveda, yoga and modern therapies, the PRAYAS centre at the All India Institute of Ayurveda in Goa is emerging as a ray of hope for children with ...

Sanofi’s venglustat met all primary endpoints in a phase 3 study of type 3 Gaucher disease In the LEAP2MONO phase 3 study, venglustat, dosed orally once daily, demonstrated clinically meaningful ...

Congenital stationary night blindness (CSNB) is caused by mutations in a specific calcium channel. A comprehensive proteomic study by researchers at the University of Innsbruck now reveals how these ...